Table 4 Frequency of eye diseases in specific age groups of the German population-based Gutenberg Health Study (GHS), 2007–2012
age decade | NEI VFQ-25 scales (LFVFS, SFVFS, LFSES, SFSES) available (81.5%) | NEI VFQ-25 missing, or at least one scale (LFVFS, SFVFS, LFSES, SFSES) missing (18.5%) | |||||
|---|---|---|---|---|---|---|---|
all % (n) | men % (n) | women % (n) | all% (n) | men % (n) | women%(n) | ||
Self-reported glaucoma | 35–44 | 0.4% (11) | 0.4% (5) | 0.4% (6) | 0.5% (2) | 0.5% (1) | 0.5% (1) |
45–54 | 1.0% (34) | 1.3% (22) | 0.7%(12) | 0.6% (3) | 0% (0) | 1.5% (3) | |
55–64 | 2.4% (84) | 2.7% (46) | 2.2% (38) | 1.6% (7) | 1.2% (3) | 2.2% (4) | |
65–74 | 5.4% (177) | 4.3% (73) | 6.6% (104) | 4.4% (18) | 4.5% (10) | 4.2% (8) | |
Self-reported ocular hypertension | 35–44 | 0.1% (2) | 0% (0) | 0.1% (2) | 0% (0) | 0% (0) | 0% (0) |
45–54 | 0.2% (6) | 0.1% (2) | 0.2% (4) | 0% (0) | 0% (0) | 0% (0) | |
55–64 | 0.2% (7) | 0.1% (2) | 0.3% (5) | 0% (0) | 0% (0) | 0% (0) | |
65–74 | 0.3% (11) | 0.5% (9) | 0.1% (2) | 0.2% (1) | 0% (0) | 0.5% (1) | |
Self-reported age-related macular degeneration (AMD) | 35–44 | 0% (0) | 0% (0) | 0% (0) | 0% (0) | 0% (0) | 0% (0) |
45–54 | 0.1% (5) | 0.2% (3) | 0.1% (2) | 0% (0) | 0% (0) | 0% (0) | |
55–64 | 0.4% (13) | 0.3% (6) | 0.4% (7) | 0.5% (2) | 0.4% (1) | 0.5% (1) | |
65–74 | 1.3% (42) | 1.1% (19) | 1.5% (23) | 2.0% (8) | 1.8% (4) | 2.1% (4) | |
Self-reported cataract | 35–44 | 0.3% (8) | 0.4% (5) | 0.2% (3) | 0% (0) | 0% (0) | 0% (0) |
45–54 | 0.3% (10) | 0.2% (3) | 0.4% (7) | 0.2% (1) | 0% (0) | 0.5% (1) | |
55–64 | 0.6% (22) | 0.5% (8) | 0.8% (14) | 0.5% (2) | 0.5% (1) | 0.5% (1) | |
65–74 | 1.4% (45) | 1.0% (16) | 1.8% (29) | 2.2% (9) | 1.4% (3) | 3.2% (6) | |
Unilateral Pseudophakia | 35–44 | 0.1% (3) | 0.2% (3) | 0% (0) | 0.2% (1) | 0.5% (1) | 0% (0) |
45–54 | 0.4% (15) | 0.6% (10) | 0.3% (5) | 0.6% (3) | 1.0% (3) | 0% (0) | |
55–64 | 1.5% (52) | 1.5% (26) | 1.5% (26) | 1.1% (5) | 1.2% (3) | 1.1% (2) | |
65–74 | 4.1% (132) | 3.3% (56) | 4.8% (76) | 4.4% (18) | 4.5% (10) | 4.2% (8) | |
Bilateral Pseudophakia | 35–44 | 0.1% (2) | 0.1% (2) | 0% (0) | 0.2% (1) | 0% (0) | 0.5% (1) |
45–54 | 0.5% (16) | 0.4% (7) | 0.5% (9) | 0.2% (1) | 0% (0) | 0.5% (1) | |
55–64 | 2.3% (80) | 2.0% (35) | 2.6% (45) | 2.1% (9) | 1.6% (4) | 2.7% (5) | |
65–74 | 9.4% (307) | 8.7% (146) | 10.3% (161) | 8.8% (36) | 9.5% (21) | 7.9% (15) | |
Self-reported diabetic retinopathy | 35–44 | 0% (0) | 0% (0) | 0% (0) | 0% (0) | 0% (0) | 0% (0) |
45–54 | 0% (0) | 0% (0) | 0% (0) | 0% (0) | 0% (0) | 0% (0) | |
55–64 | 0.2% (7) | 0.2% (3) | 0.2% (4) | 0% (0) | 0% (0) | 0% (0) | |
65–74 | 0.2% (7) | 0.4% (6) | 0.1% (1) | 0.7% (3) | 0.9% (2) | 0.5% (1) | |
Self-reported strabism | 35–44 | 3.8% (106) | 4.0% (54) | 3.5% (52) | 2.2% (9) | 2.8% (6) | 1.6% (3) |
45–54 | 3.1% (105) | 3.0% (51) | 3.1% (54) | 2.0% (10) | 2.7% (8) | 1.0% (2) | |
55–64 | 2.6% (89) | 2.3% (40) | 2.8% (49) | 1.8% (8) | 1.2% (3) | 2.7% (5) | |
65–74 | 1.9% (61) | 1.9% (32) | 1.8% (29) | 1.7% (7) | 2.3% (5) | 1.1% (2) | |
Self-reported color deficiency | 35–44 | 0.3% (9) | 0.7% (9) | 0% (0) | 0% (0) | 0% (0) | 0% (0) |
45–54 | 0.1% (4) | 0.2% (3) | 0.1% (1) | 0% (0) | 0% (0) | 0% (0) | |
55–64 | 0.3% (9) | 0.5% (9) | 0% (0) | 0% (0) | 0% (0) | 0% (0) | |
65–74 | 0.1% (2) | 0.1% (2) | 0% (0) | 0% (0) | 0% (0) | 0% (0) | |